| Literature DB >> 25082324 |
T Lencioni1, M Rabuffetti2, G Piscosquito3, D Pareyson3, A Aiello4, E Di Sipio5, L Padua5, F Stra6, M Ferrarin2.
Abstract
The aim of the present study was to assess postural stabilization skill in adult subjects affected by Charcot-Marie-Tooth disease (CMT) type 1A. For this purpose ground reaction force (GRF) was measured by means of a piezoelectric force platform during the sit-to-stand (STS) movement, until a steady state erect posture was achieved. Specific indexes to quantify Centre of Mass acceleration, both during postural stabilization and during quiet standing, were computed using a mathematical model. Forty-seven CMT1A subjects were recruited for the study, and the control group was formed by forty-one age- and sex-matched healthy subjects. The results show that CMT1A subjects are less stable than controls during the quiet stance. Greater difficulty (high values of Yinf, the final instability rate) to maintain erect posture appears to be mainly associated with plantar-flexor muscle weakness, rather than to damage of the proprioceptive system. The worst performances shown by CMT1A subjects in the stabilization phase (high values of I, the global index of postural stabilization performance) seem to be associated with reduced muscle strength and the loss of large sensory nerve fibres. Distal muscle weakness appears to affect both postural stabilization and quiet erect posture. The presented protocol and the analysis of postural stabilization parameters provide useful information on CMT1A balance disorders.Entities:
Keywords: Balance; Charcot–Marie–Tooth; Muscle strength; Plantar flexion; Posture
Mesh:
Year: 2014 PMID: 25082324 PMCID: PMC4180012 DOI: 10.1016/j.gaitpost.2014.07.006
Source DB: PubMed Journal: Gait Posture ISSN: 0966-6362 Impact factor: 2.840
Demographic and anthropometric data for control and CMT1A group and clinical data for CMT1A group; mean (SD).
| Group | Controls | CMT 1A | |
|---|---|---|---|
| 41 | 47 | ||
| Age [years] | 44.1 (18.1) | 44.5 (12.0) | |
| Height [cm] | 169.0 (10.7) | 166.8 (11.1) | |
| Body mass [kg] | 68.2 (14.5) | 67.1 (15.3) | |
| Total | – | 7.6 (3.8) | |
| Sensory symptoms | – | 0.9 (1.1) | |
| Motor symptoms legs | – | 1.1 (0.6) | |
| CMTES | Motor symptoms arms | – | 0.6 (0.6) |
| Pin sensibility | – | 1.3 (1.0) | |
| Vibration sense | – | 1.1 (0.8) | |
| Strength legs | – | 1.4 (1.0) | |
| Strength arms | – | 1.3 (1.0) | |
| Hip flexor | – | 4.9 (0.2) | |
| Knee flexor | – | 4.9 (0.2) | |
| MRC | Knee extensor | – | 4.8 (0.2) |
| Ankle dorsi-flexor (ADF) | – | 3.3 (1.5) | |
| Ankle plantar-flexor (APF) | – | 4.2 (1.2) | |
| Total | – | 3.0 (1.6) | |
| ONLS | Legs | – | 1.7 (0.9) |
| Arms | – | 1.3 (1.1) | |
| VAS pain | Total | – | 3.1 (2.8) |
| Walk12 | Total | – | 27.1 (10.7) |
MRC, Medical Research Council scale for muscle strength; CMTES, Charcot–Marie–Tooth examination score; ONLS, Overall Neuropathy Limitations Scale; VAS, Visual Analogue Scale.
Fig. 1(A) and (C) Algorithm for t0 identification based on an analysis of vertical and anterior–posterior components of ground reaction force (GRFV and GRFAP) derived by Etnyre et al. [26] for a healthy subject and a severe CMT1A patient. For better visualization, GRFAP is magnified by a factor 3 identification of t0 (time instant corresponding to the end of macroscopic movement): (1) maximum vertical force peak is identified (corresponding to maximum vertical inertia); (2) following minimum force peak is identified (corresponding to minimum vertical inertia); (3) t0 is defined as the first sample higher than body weight. (B) and (D) Root mean square of antero-posterior component of the ground reaction force (RMSAP) and fitting of the negative exponential model plotted versus time for a healthy subject and a severe CMT1A subject with all model parameters altered.
Postural stabilization parameters for control and CMT1A group; mean (SD).
| Parameters | Controls | CMT 1A |
|---|---|---|
| 0.78 (0.40) | 1.21 (0.58) | |
| 0.084 (0.038) | 0.092 (0.039) | |
| 0.059 (0.024) | 0.106 (0.072) | |
| 0.010 (0.003) | 0.018 (0.013) |
T: time duration of postural stabilization; Y0: residual instability at the beginning of the stabilization phase; I: global index of performance during stabilization; Yinf: the residual instability after stabilization in quiet standing.
* Statistical significant differences between Controls and CMT1A are indicated with p < 0.05.
Statistical significant differences between Controls and CMT1A are indicated with p < 0.001.
*** Statistical significant differences between Controls and CMT1A are indicated with p < 0.0001.
Fig. 2(A) Scatter-plots of T vs. Y0 for control and CMT1A groups during STS task. Dotted line represents the limiting curve of control group Y0 * T = I95, the 95th percentile of healthy subjects’ I. (B) Scatter plot of I vs. CMTES. In grey, subjects with parameter I lower than the limit of the 95th percentile of the controls distribution (dotted line represents I95 = 0.095 [m s−1]).
Correlation coefficient values ρ between postural stabilization parameters and CMTES, VAS pain, vibration sense, strength legs, distal and proximal muscles MRC.
| Clinical parameters | ||
|---|---|---|
| CMTES total | 0.47 | 0.28 |
| VAS pain | −0.03 | 0.07 |
| Vibration sense | 0.31 | 0.01 |
| Strength legs | 0.57 | 0.34 |
| MRC ankle dorsi-flexors (ADF) | −0.46 | −0.37 |
| MRC ankle plantar-flexors (APF) | −0.41 | −0.66 |
| MRC knee flexors | −0.12 | −0.39 |
| MRC knee extensors | −0.13 | −0.38 |
| MRC hip flexors | −0.16 | −0.30 |
MRC, Medical Research Council scale for muscle strength; CMTES, Charcot–Marie–Tooth examination score.
The level of statistical significance of ρ coefficients is indicated with p < 0.05.
The level of statistical significance of ρ coefficients is indicated with p < 0.001.
The level of statistical significance of ρ coefficients is indicated with p < 0.0001.